LAURA DORWART: Open Payments
NPI 1538215249 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 21 payments from 9 companies in 2025. Trend: 2023 $53 · 2024 $400 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $110 |
| Amgen Inc. | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| ABIOMED | 2 | $48 |
| Boston Scientific Corporation | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Philips North America LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
Products named: VERQUVO, REPATHA, JARDIANCE, Kerendia, WATCHMAN FLX, ONPATTRO, MCOT, Wegovy.
Industry payments across OK — which companies pay providers there.
